Bloomberg Law reports that the President’s proposed budget may finally bring about long-awaited CBD regulations from the FDA:
“Cannabis regulation is a new top-line priority for the FDA as Congress demands better research and the cannabis-derived supplement CBD grows in popularity, according to President Donald Trump’s budget proposal released Monday.
Read more here.
“Should Kade or other medically fragile Minnesota children be denied an education because the safest medication for them comes from a plant? School nurses should want to give medication with the least amount of side effects and greatest efficacy, and for students like Kade, that lifesaving medication is hemp-derived CBD and/or medical cannabis.”
We mentioned the Star Tribune’s article on CBD in Minnesota schools previously here on the Stigma blog and today brings us a strong and well worded opinion piece from the newspaper’s continuing coverage on the issue. Read it here, and let us know what you think in the comments.
“In short, experts say, social and racial equity must become foundations rather than buzzwords in cannabis — and be treated as complex processes, needing patience and investment — if this entire industry is going to succeed. A key reason is that our nation’s giant cannabis industry is a patchwork of underground and state-level or municipally legal sources, with a long history of mostly being innovated and (literally) cultivated by, and weaponized against, people of color.” Janet Burns, Forbes (January 8, 2020).
An excellent article from Forbes offers a strong perspective on the importance of a social justice component in modern legal canna-business. Give it a read!
Nearly everyone involved with the business end of the CBD industry is wondering how and when the CBD will begin to sort out the regulatory snarl that has arisen in making these cannabinoid-enhanced products. This article poses many interesting questions and presents several interesting points of view which, if you are interested on what might happen to your favorite CBD products in the near future, is certainly worth reading.
While the news is a few months old at this point, we here at Stigma are still glowingly proud of winning an award for being the “best Minnesota CBD shop” at the first annual Legacy Cannabidiol Cup.
Have you visited our shop yet? We’re located at 250 3rd Avenue N., in Minneapolis’ North Loop neighborhood. Stop in and say hello!
“Kade can descend into a grand mal seizure at any moment. Outside of school, King can rush to her son’s side and administer his CBD oil, which has an almost immediate effect. It calms his contracting muscles and slows his breathing until he wakes minutes later.” Read more in the complete article, linked below.
Instructions for use (Oil):
Stigma CBD Oil is designed to be used as a sublingual tincture. Take a half dropper full or more and hold under your tongue for 30 seconds to a minute before swallowing. If preferred, the tincture can be immediately swallowed—a higher dosage is suggested if taken in this method.
To achieve maximum results, it is suggested that the chosen dosage is taken once or twice daily and with consistency.
Instructions for use (Gummies):
Stigma CBD gummies are designed for long lasting and saturating effect. Take one (10mg) or more gummies with each meal of the day. As the gummies and your food break down progressively throughout the day, the CBD will slowly be released into your bloodstream.
Instructions for use (Gel Caps):
Stigma Gel Caps are extra strength (25mg) and designed to be rapidly absorbed and released into the bloodstream for a concentrated effect.